major-funding-2025

$5 million, Mental Health Services Oversight and Accountability Commission
Project: Early Psychosis Training and Technical Assistance

$2.17 million, Health Management Associates, Inc. (Michigan)
Project: The Good Life Healthy Aging program

$1.57 million, NIH National Institute of Mental Health
Project: California Collaborative Network to Promote Data Driven Care and Improve Outcomes in Early Psychosis

$5.2 million, National Institutes of Health (NIH) National Institute on Aging 
Project: Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old

$3.25 million, NIH National Institute on Aging 
Project: KHANDLE: Kaiser Healthy Aging and Diverse Life Experiences Study

$8.39 million, California Department of Public Health
Project: California Epidemiologic Investigation Service (Cal-EIS) Fellowship Program

$6.4 million, Patient-Centered Outcomes Research Institute
Project: In Person vs. Telehealth Opioid Use Disorder Treatment after Patients Leave the Emergency Department

$4.59 million, California Institute for Regenerative Medicine
Project: Superior Forward-Oriented b-Globin Vector for Treating Sickle Cell Disease

$4.48 million, California Institute for Regenerative Medicine
Project: Expression of Ube3a by the Hematopoietic System for the Treatment of Angelman Syndrome

$1.8 million, Public Health Services (PHS) Health Resources and Services Administration
Project: UC Davis Health Institute on Wildfires, Health, Equity, and Resilience

$1.6 million, NIH National Institute of Environmental Health Sciences 
Project: The CHARGE Study Phase II: A Multifactorial Approach to Autism Etiology

$3 million, Coalition For Epidemic Preparedness Innovations
Project: Improving Virus Risk-ranking to Better Anticipate Disease X Emergence in Humans and Target Mitigation Measures

$1.24 million, California Department of Public Health
Level 2 Special Pathogen Treatment Center

$2.8 million, UC Tobacco-Related Disease Research Program
Project: UC Davis Tobacco Cessation Policy Research Center (UCD TCPRC)

$1.43 million, Agricultural Labor Relations Board
Project: California Farmworker Outreach Development

$1 million, California Labor and Workforce Development Agency
Project: Statewide Agriculture and Farmworker Education (SAFE) Program

$2.7 million, Medical Technology Enterprise Consortium
Project: Improving Modular Patient Admission Capacity Through Scalable Solutions (IMPACTS)

$2.4 million, Foundation for California Community Colleges
Project: Greater Northern California Regional Healthcare (GNCRHH)

$2.2 million, Department of Health and Human Services National Institute for Occupational Safety and Health
Project: Western Center for Agricultural Health and Safety

$1.8 million, Department of Defense (DOD) Congressionally Directed Medical Research Program
Project: Contribution of Bone Mass and Fracture to Bone Metastasis in Prostate Cancer

$1.7 million, California Office of Traffic Safety
Project: Drug and Alcohol Use in Motor Vehicle Crash Victims - Year 2

$1.6 million, Department of Justice (DOJ) National Institute of Justice
Project: REFRAME: Research and Evaluation Framework for Reducing hArm and Measuring the Effectiveness of CVIPI Strategies

$1.28 million, California Department of Health Care Services
Project: Together for Wellness/Juntos por Nuestro Bienestar

$1.2 million, NIH National Institute on Aging
Project: Vietnamese Insights into Cognitive Aging Program (VIP)

$1.2 million, UC Los Angeles
Project: UCLA-UCSF ACEs Aware Family Resilience Network (UCAAN)

$1.16 million, NIH National Institute of Neurological Disorders & Stroke
Project: Trajectories and Markers of Neurodegeneration in Carriers of the Fragile X Premutation

$1.16 million, DOD Congressionally Directed Medical Research Program
Project: Functional and phenotypic metabolic transitions governing disease state in clear cell renal cell carcinoma

$1.1 million, NIH National Institute on Aging
Project: The Neuropathologic Landscape of Alzheimer's Disease in Hispanic Descendents

$1.1 million, UC Berkeley
Project: Surgical Robotics and Health Informatics Training Program

$1 million, NIH National Institute on Aging
Project: Brain pathologies, Reserve and Cognition in Aging and Dementia

$1 million, MARABio Systems Inc.
Project: Work for contract between UC Davis Van de Water lab and MARABio

$5.25 million, Merck & Co., Inc.
A Phase 2/3 Open-Label Study to Evaluate Neoadjuvant & Adjuvant V940 (mRNA-4157) in Combination with Pembrolizumab (MK-3475) versus SOC, and Pembrolizumab Monotherapy in Participants with Squamous Cell Carcinoma (LA cSCC) (INTerpath-007)

$3.6 million, Merck Sharp & Dohme LLC
A Phase 3, Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment with One Nextge

$2.69 million, Janssen Research & Development, LLC
A Phase 3 Study to Assess Efficacy, Safety & Immunogenicity of Vaccination w/ ExPEC9V in Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Yrs & Older w/ History of UTI in Past Two Years

$2 million, Abbvie Inc.
A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderate to Severe Crohn's Disease

$1.2 million, Inhibrx, Inc.
A Phase 2, Active-Control, Parallel Group Study to Assess INBRX-101 Compared to Plasma Derived ALPHA-Proteinase Inhibitor (A1PI) Augmentation Therapy in Adults with ALPHA-1 Antitrypsin Deficiency (AATD) Emphysema.

$1.8 million, Glaxosmithkline PLC
A Clinical Trial to Evaluate the Efficacy and Safety Profile of Dostarlimab in Combination with Belrestotug when Compared with Pembrolizumab and Placebo in Participants with Previously Untreated, Unresectable, Locally Advanced or Metastatic PD-L1 High NSCLC

$1.4 million, Cabaletta Bio, Inc.
A Phase 1, Open-label, Safety and Dosing Study of Autologous Desmoglein 3 Chimeric Autoantibody Receptor T Cells (DSG3-CAART) in Subjects with Active, Anti-DSG3, Mucosal-dominant Pemphigus Vulgaris

$1.2 million, Marengo Therapeutics, Inc.
A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR)-targeting, Bifunctional Antibody-fusion Molecule, in Subjects with Unresectable, Locally Advanced, or Metastatic Solid Tumors

$1.1 million, Balmoral Medical, LLP
A Prospective, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Effectiveness of the Transdermal Compress Device in Participants with Transfemoral Amputations

$1 million, Pfizer Inc.
A Phase 3, Open-Label Study of Elranatamab Monotherapy Versus Elotuzumab, Pomalidomide, Dexamethasone (EPd) or Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants with Relapsed/Refractory Multiple Myeloma Who Received Prior Anti-CD38 Directed Therapy

$10 million, NIH National Institute of Neurological Disorders & Stroke
Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)

$3.2 million, NIH National Institute on Aging
UC Davis Alzheimer’s Disease Center

$5.12 million, NIH National Center for Advancing Translational Sciences
UC Davis Clinical and Translational Science Center

$3.6 million, National Cancer Institute
Comprehensive Cancer Center Support Grant

$3.6 million, National Institute of Allergy and Infectious Diseases
HIV FP cocktail vaccines designed for optimal follicular T and B cell induction and efficacy (Opti-FliP)

$3.1 million, NIH National Institute of Child Health & Human Development
California Partnership for Personalized Nutrition

$3.1 million, NIH National Institute of Mental Health
UC Davis Conte Center: Neuroimmune Mechanisms of Psychiatric Disorders

$2.47 million, NIH National Cancer Institute
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice

$1.3 million, NIH National Institutes of Health Office of the Director
Center for Somatic Cell Genome Editing in Nonhuman Primates

$1.25 million, NIH National Institute of Child Health & Human Development
MIND Institute Intellectual and Developmental Disabilities Research Center (IDDRC)

$1.15 million, NIH National Institute of Biomedical Imaging and Bioengineering
The National Center for Interventional Biophotonic Technologies (NCIBT)

$1.1 million, NIH Office of Research Infrastructure Programs
Mutant Mouse Resource and Research Center (MMRRC) at UC Davis